{"entity":{"id":"nct07251582","kind":"trial","name":"Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer","aka":["LungTime-C02"],"tldr":"A phase 3 trial in lung cancer, run by Hunan Province Tumor Hospital, now recruiting.","summary":"Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer is a phase 3, randomised interventional study registered as NCT07251582 by Hunan Province Tumor Hospital, with a registry enrolment figure of 186 participants, started 2026-08-12 and due to reach its primary completion in 2028-10-31. Interventions recorded: Time of Day-based Assignment for Infusion of Immune Checkpoint Inhibitor (e.g., toripalimab, or pembrolizumab) + platinum-based chemotherapy. Conditions listed: Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC). Primary outcome: Pathological Complete Response (pCR) rate. Lung eligibility wording from the registry: \"Histologically or cytologically confirmed diagnosis of resectable stage II to III non-small cell lung cancer (NSCLC)\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07251582","url":"https://clinicaltrials.gov/study/NCT07251582"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["resectable-nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07251582","phase":"3","setting":"A Prospective Study on the Effect of Infusion Timing of Immune Checkpoint Inhibitors on Pathologic Response in Patients With Resectable Stage II-III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Therapy","sponsor":"Hunan Province Tumor Hospital","enrolled":186,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07251582/","neighbours":{"cancer":[{"id":"resectable-nsclc","kind":"cancer","name":"Resectable stage I to III non-small-cell lung cancer","route":"/cancers/resectable-nsclc/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}